Healthcare & Life Sciences
NeuroPhage
Israel
acquiredseries-a
series-a
Stage
1
Investors
About
NeuroPhage is a biotechnology company focused on developing novel therapies for neurodegenerative diseases using bacteriophage technology.
Explore NeuroPhage's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.